The cost of waiting
7.7M from bacterial infections and 8.7M from six major viral diseases.
The faster a pathogen is identified, the sooner treatment, isolation and public-health action can begin.
Up to 15% of diagnoses are estimated to be inaccurate, delayed or wrong.
When symptoms overlap, a rapid molecular result turns uncertainty into a targeted next step.
Our estimate of the yearly cost of diagnosis, misdiagnosis and delay across human and animal health.
Earlier answers reduce unnecessary treatment, lost productivity and the spread of resistant pathogens.
Laboratory-grade answers, right where decisions are made.
Every setting
Vivoxa brings the molecular laboratory to the point of need. A single run resolves multiple bacterial and viral pathogens, without a bench, a cold chain, or a technician.
Clinics and pharmacies, with molecular answers at the point of care.
The exact pathogen and resistance profile, targeted from the first dose.
Racing yards, stud farms and vets, testing at the stable door.
UTIs, ear and skin infections, answered in the same visit.
From mastitis screening to herd-wide outbreaks.
Catching spillover pathogens before they reach livestock or people.
Read as light
Designed for one swab, one run, multiple answers.
How it works
Add the swab to the buffer, then load it into the reader. No pipettes or lab prep.
Start the run. The instrument analyses multiple targets in a single assay.
See a clear result in under 30 minutes, ready to guide the next decision.
About
Assay science, device engineering and go-to-market, with prior experience in diagnostics companies.
Co-founder & CEO
MBiochem Biochemistry
Co-founder & COO
DPhil Engineering Science
Founding Engineer
DPhil Engineering Biology
Engineer / Advisor
DPhil Engineering Science
Outreach Officer
MSc Health Innovation
Milestones
Contact
Pre-launch, and we reply to everyone.